Trials / Recruiting
RecruitingNCT07228806
Effectiveness of Telerehabilitation on Pelvic Floor Dysfunction at Postpartum Woman
Evaluation of the Effectiveness of Telerehabilitation on Pelvic Floor Dysfunction in Postpartum Women: A Single-Blind Randomised Controlled Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Ankara Etlik City Hospital · Other Government
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
These events are largely due to pelvic floor dysfunction that develops after pregnancy. Kegel exercises and core stabilisation exercises performed in the postpartum period are important in preventing pelvic floor dysfunction. However, considering the mother's adaptation process to both the baby and her new life in the postpartum period, there may be problems with exercise compliance. Increasing exercise compliance through telerehabilitation can be effective in preventing pelvic floor dysfunction and improving women's quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pelvic floor exercises with telerehabilitation | Patients in the telerehabilitation group will be assigned the same 8-week exercise programme as those in the conventional group to be carried out at home. Unlike the conventional group, patients in the telerehabilitation group will be contacted by telephone each week throughout the exercise programme to check their adherence to the programme, to ask if they have encountered any problems with the exercise programme, and to answer any questions they may have. |
| OTHER | Pelvic floor exercises without telerehabilitation | An 8-week exercise programme consisting of 45-minute Kegel exercises and core stabilisation exercises per day will be provided for implementation at home in the conventional group. |
Timeline
- Start date
- 2025-11-30
- Primary completion
- 2026-05-09
- Completion
- 2026-05-09
- First posted
- 2025-11-14
- Last updated
- 2026-02-24
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07228806. Inclusion in this directory is not an endorsement.